| BELLEVUE FUNDS (LUX) - BELLEVUE EMERGING MARKETS HEALTHCARE B USD | SALUD | 10,06% | -16,89% | -39,08% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 24,14% | 6,68% | -39,19% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 34,10% | 1,01% | -39,24% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 24,07% | 6,52% | -39,31% | · |
| TEMPLETON GLOBAL TOTAL RETURN A (YDIS) EUR-H1 | RFI GLOBAL | 7,69% | -11,89% | -39,33% | -60,95% |
| ABRDN SICAV I-CHINA A SHARE SUSTAINABLE EQUITY FUND A ACC EUR HEDGED | RVI CHINA | 32,90% | -9,68% | -39,36% | · |
| FIDELITY FUNDS-CHINA CONSUMER E-ACC-EUR | CONSUMO | 17,57% | -13,85% | -39,43% | 19,80% |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 24,00% | 6,40% | -39,43% | · |
| MULTIUNITS LUX - AMUNDI EURO GOVERNMENT BOND 15+Y UCITS ETF ACC EUR | DEUDA PÚBLICA EURO | -3,37% | -3,38% | -39,45% | · |
| BGF ASIAN TIGER BOND A8 NZD (HEDGED) | RFI ASIA/OCEANÍA | -6,91% | -14,68% | -39,56% | -42,33% |
